Interference with lysophosphatidic acid receptor 5 ameliorates oxidized low-density lipoprotein-induced human umbilical vein endothelial cell injury by inactivating NOD-like receptor family, pyrin domain containing 3 inflammasome signaling

References

• Khyzha N, Alizada A, Wilson M, et al. Epigenetics of atherosclerosis: emerging mechanisms and methods. Trends Mol Med. 2017;23(4):332–347.
   PubMed Web of Science ®Google Scholar
• Lusis AJ. Atherosclerosis. Nature. 2000;407(6801):233–241.
   PubMed Web of Science ®Google Scholar
• Roger VL. Cardiovascular diseases in populations: secular trends and contemporary challenges-Geoffrey Rose lecture, European Society of Cardiology meeting 2014. Eur Heart J. 2015;36(32):2142–2146.
   PubMed Web of Science ®Google Scholar
• Gimbrone M, García-Cardeña G, Cell E. Dysfunction and the pathobiology of atherosclerosis. Circ Res. 2016;118(4):620–636.
   PubMed Web of Science ®Google Scholar
• Kattoor A. Kanuri S and Mehta J: role of Ox-LDL and LOX-1 in atherogenesis. Curr Med Chem. 2019;26(9):1693–1700.
   PubMed Web of Science ®Google Scholar
• Pandey D, Bhunia A, Oh Y, et al. OxLDL triggers retrograde translocation of arginase2 in aortic endothelial cells via ROCK and mitochondrial processing peptidase. Circ Res. 2014;115(4):450–459.
   PubMed Web of Science ®Google Scholar
• Kattoor A, Pothineni N, Palagiri D, et al. Oxidative stress in atherosclerosis. Curr Atheroscler Rep. 2017;191.
   PubMedGoogle Scholar
• Choi J, Herr D, Noguchi K, et al. LPA receptors: subtypes and biological actions. Annu Rev Pharmacol Toxicol. 2010;50(1):157–186.
   PubMed Web of Science ®Google Scholar
• Zhou Y, Little P, Cao Y, et al. Lysophosphatidic acid receptor 5 transactivation of TGFBR1 stimulates the mRNA expression of proteoglycan synthesizing genes XYLT1 and CHST3. Biochimica et biophysica acta. Molecular cell research. 1867;118848:2020.
   Google Scholar
• Khandoga A, Pandey D, Welsch U, et al. GPR92/LPA₅ lysophosphatidate receptor mediates megakaryocytic cell shape change induced by human atherosclerotic plaques. Cardiovasc Res. 2011;90(1):157–164.
   PubMed Web of Science ®Google Scholar
• Li D, Liu M, Li Z, et al. Sterol-resistant SCAP overexpression in vascular smooth muscle cells accelerates atherosclerosis by increasing local vascular inflammation through activation of the NLRP3 inflammasome in mice. Aging Dis. 2021;12(3):747–763.
   PubMed Web of Science ®Google Scholar
• Huang D, Gao W, Zhong X, et al. NLRP3 activation in endothelia promotes development of diabetes-associated atherosclerosis. Aging (Albany NY). 2020;12(18):18181–18191.
   PubMedGoogle Scholar
• Wu Q, He X, Wu L, et al. MLKL Aggravates Ox-LDL-induced cell pyroptosis via activation of NLRP3 inflammasome in human umbilical vein endothelial cells. Inflammation. 2020;43(6):2222–2231.
   PubMed Web of Science ®Google Scholar
• Gaire B, Lee C, Kim W, et al. Lysophosphatidic acid receptor 5 contributes to imiquimod-induced psoriasis-like lesions through NLRP3 inflammasome activation in macrophages. Cells. 2020;9.
   Web of Science ®Google Scholar
• Lee H, Kim J, Kim H, et al. Upregulated NLRP3 inflammasome activation in patients with type 2 diabetes. Diabetes. 2013;62(1):194–204.
   PubMed Web of Science ®Google Scholar
• Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2001;25(4):402–408.
   PubMed Web of Science ®Google Scholar
• Desjardins F, Balligand J. Nitric oxide-dependent endothelial function and cardiovascular disease. Acta Clin Belg. 2006;61(6):326–334.
   PubMed Web of Science ®Google Scholar
• Geng J, Xu H, Yu X, et al. Rosuvastatin protects against oxidized low‑density lipoprotein‑induced endothelial cell injury of atherosclerosis in vitro. Mol Med Rep. 2019;19:432–440.
   PubMed Web of Science ®Google Scholar
• Mozaffarian D, Benjamin E, Go A, et al. Heart disease and stroke statistics–2015 update: a report from the American Heart Association. Circulation. 2015;131:e29–322.
   PubMed Web of Science ®Google Scholar
• Libby P. Inflammation in atherosclerosis. Nature. 2002;420(6917):868–874.
   PubMed Web of Science ®Google Scholar
• Fan J, Watanabe T. Inflammatory reactions in the pathogenesis of atherosclerosis. J Atheroscler Thromb. 2003;10(2):63–71.
   PubMedGoogle Scholar
• Luo Y, Lu S, Dong X, et al. Sun G and Sun X: dihydromyricetin protects human umbilical vein endothelial cells from injury through ERK and Akt mediated Nrf2/HO-1 signaling pathway. Apoptosis. 2017;22(8):1013–1024.
   PubMed Web of Science ®Google Scholar
• Zhong X, Li P, Li J, et al. Downregulation of microRNA‑34a inhibits oxidized low‑density lipoprotein‑induced apoptosis and oxidative stress in human umbilical vein endothelial cells. Int J Mol Med. 2018;42:1134–1144.
   PubMed Web of Science ®Google Scholar
• Burris R, Xie C, Thampi P, et al. Melnyk S and Nagarajan S: dietary rice protein isolate attenuates atherosclerosis in apoE-deficient mice by upregulating antioxidant enzymes. Atherosclerosis. 2010;212(1):107–115.
   PubMed Web of Science ®Google Scholar
• Luo T, Deng Z, Li X, et al. Triolein and trilinolein ameliorate oxidized low-density lipoprotein-induced oxidative stress in endothelial cells. Lipids. 2014;49(5):495–504.
   PubMed Web of Science ®Google Scholar
• Kovacic J, Mercader N, Torres M. Boehm M and Fuster V: epithelial-to-mesenchymal and endothelial-to-mesenchymal transition: from cardiovascular development to disease. Circulation. 2012;125(14):1795–1808.
   PubMed Web of Science ®Google Scholar
• Chen P, Qin L, Baeyens N, et al. Endothelial-to-mesenchymal transition drives atherosclerosis progression. J Clin Invest. 2015;125(12):4514–4528.
   PubMed Web of Science ®Google Scholar
• Li H, Zhao Q, Chang L, et al. LncRNA MALAT1 modulates ox-LDL induced EndMT through the Wnt/β-catenin signaling pathway. Lipids Health Dis. 2019;18(62). DOI:10.1186/s12944-019-1006-7.
   Google Scholar
• Boström K, Yao J, Guihard P. Blazquez-Medela A and Yao Y: endothelial-mesenchymal transition in atherosclerotic lesion calcification. Atherosclerosis. 2016;253:124–127.
   PubMed Web of Science ®Google Scholar
• Lee W, Ou H, Hsu W, et al. Ellagic acid inhibits oxidized LDL-mediated LOX-1 expression, ROS generation, and inflammation in human endothelial cells. J Vasc Surg. 2010;52(5):1290–1300.
   PubMed Web of Science ®Google Scholar
• Yao Y, Wang Y, Zhang Y, et al. Klotho ameliorates oxidized low density lipoprotein (ox-LDL)-induced oxidative stress via regulating LOX-1 and PI3K/Akt/eNOS pathways. Lipids Health Dis. 2017;16(77). DOI:10.1186/s12944-017-0447-0
   Google Scholar
• Li J, Li A, Li M, et al. Ginkgolic acid exerts an anti-inflammatory effect in human umbilical vein endothelial cells induced by ox-LDL. Pharmazie. 2018;73:408–412.
   PubMed Web of Science ®Google Scholar
• Qi J, Zheng J, Ai W, et al. Felodipine inhibits ox-LDL-induced reactive oxygen species production and inflammation in human umbilical vein endothelial cells. Mol Med Rep. 2017;16(4):4871–4878.
   PubMed Web of Science ®Google Scholar
• Hoseini Z, Sepahvand F, Rashidi B, et al. NLRP3 inflammasome: its regulation and involvement in atherosclerosis. J Cell Physiol. 2018;233(3):2116–2132.
   PubMed Web of Science ®Google Scholar
• Martínez G. Celermajer D and Patel S: the NLRP3 inflammasome and the emerging role of colchicine to inhibit atherosclerosis-associated inflammation. Atherosclerosis. 2018;269:262–271.
   PubMed Web of Science ®Google Scholar
• Jiang Y, Wang M, Huang K, et al. Oxidized low-density lipoprotein induces secretion of interleukin-1β by macrophages via reactive oxygen species-dependent NLRP3 inflammasome activation. Biochem. Biophys. Res. Commun. 2012;425(2):121–126.
   PubMed Web of Science ®Google Scholar
• Qian W, Cai X, Qian Q, et al. Astragaloside IV protects endothelial progenitor cells from the damage of ox-LDL via the LOX-1/NLRP3 inflammasome pathway. Drug Des Devel Ther. 2019;13:2579–2589.
   PubMed Web of Science ®Google Scholar